ADRO MENU

About ADRO

Aduro Biotech, Inc. is a clinical-stage immuno-oncology company focused on the development of technology platforms to stimulate an immune response against cancer. Aduros lead platform is based on proprietary strains of live-attenuated, double-deleted (LADD) Listeria monocytogenes that induce a potent innate immune response and have been engineered to express tumor-associated antigens to induce tumor-specific T cell-mediated immunity. Aduro has received Breakthrough Therapy designation from the FDA for its lead LADD regimen, CRS-207 in combination with GVAX Pancreas in pancreatic cancer. The company is evaluating the proprietary immuno-oncology combination in the ongoing Phase 2b ECLIPSE clinical trial and has additional ongoing clinical trials with its LADD platform in mesothelioma and glioblastoma. The company is also developing clinical candidates using cyclic dinucleotide (CDN) synthetic small molecule immune modulators that are designed to activate the intracellular STING receptor, a central mediator of the innate immune response.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADRO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 197.3 M 1.9728E+08 227 227 0.0% 4.40634E-05 19 K 18878
UBIO Proshares UltraPro Nasdaq Biotechnology 24.7 M 2.47387E+07 222 222 0.0% 2.24064E-05 2 K 1858
URTY ProShares UltraPro Russell2000 94.3 M 9.4325E+07 2,000 2000 0.0% 9.31772E-06 3 K 2790
UWM ProShares Ultra Russell2000 180.7 M 1.80718E+08 1,999 1999 0.0% 1.37962E-05 5 K 5401
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 1.9 B 1.9294E+09 1,430 1430 0.0% 3E-05 60 K 59845
IBB iShares Nasdaq Biotechnology Index Fund 7.3 B 7.25697E+09 216 216 0.01% 0.0001 808 K 807924
ITOT iShares Core S&P Total U.S. Stock Market ETF 24.3 B 2.42922E+10 3,557 3557 0.0% 0 22 K 21592
IWC iShares Microcap ETF 816.7 M 8.16666E+08 1,387 1387 0.02% 0.0002 178 K 178040
IWM iShares Russell 2000 ETF 45.3 B 4.52671E+10 1,987 1987 0.0% 0 1.5 M 1482520
IWN iShares Russell 2000 Value ETF 9.4 B 9.44381E+09 1,387 1387 0.0% 0 68 K 67781
IWO iShares Russell 2000 Growth ETF 9.3 B 9.30689E+09 1,154 1154 0.01% 0.0001 590 K 589919
IWV iShares Russell 3000 ETF 10.0 B 1.00074E+10 2,884 2884 0.0% 0 25 K 24946
IEIH iShares Evolved U.S. Innovative Healthcare ETF 5.3 M 5342590 218 218 0.0% 0 202 202
VHT Vanguard Health Care ETF 9.0 B 8.999999E+09 382 382 0.0% 1.31285E-05 119 K 118510
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.5 B 1.48129E+09 2,223 2223 0.0% 4E-06 6 K 5997
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 369 369 0.0% 1.29986E-05 20 K 20167
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.0% 2.70828E-05 58 K 57569